作者: Yanyan Li , Xuelei Ma , Xi Wu , Xiaoxiao Liu , Lei Liu
DOI: 10.1111/TBJ.12303
关键词:
摘要: Survivin, an inhibitor of apoptosis protein, is a potentially prognostic factor and therapeutic target in breast carcinoma, but no consensus exists based on heterogeneous data. The aim of …